Coverage
Filings
| Filing | Date |
|---|---|
| Trading by management and close relations of management | 4 Nov 2024 |
| Major shareholder announcement | 23 Oct 2024 |
| New employee-elected board member | 21 Oct 2024 |
| Trading by management and close relations of management | 16 Oct 2024 |
| Major shareholder announcement | 15 Oct 2024 |
| Major shareholder announcement | 9 Oct 2024 |
| Major shareholder announcement | 3 Oct 2024 |
| Trading by management and close relations of management | 16 Sept 2024 |
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| Trading by management and close relations of management | 12 Sept 2024 |
| Trading by management and close relations of management | 11 Sept 2024 |
| Major shareholder announcement | 10 Sept 2024 |
| Major shareholder announcement | 6 Sept 2024 |